TRPV2 and osteosarcoma: The U2OS osteosarcoma cells overexpressing TRPV2 when receiving TRPV2–PCNH+laser resulted in downregulated β-catenin (associated with carcinogenesis) expression in contrast to the non-laser-treated TRPV2–PCNH and control group (Figure 8L).